Broadcasting News

Son Dam-bi Responds to Controversy Over Soap Bubble Play at Her Accommodation: "I Wiped the Whole Floor Clean"

Son Dam-bi Plays with Soap Bubbles with Her Daughter at Their Home Issued a clarification after controversy over causing a nuisance arose

Gim Ga Yeong
2026-07-06 15:26:26
[Edaily Starin Gim Ga Yeong Reporter] Singer and actress Son Dam-bi has been embroiled in a controversy over causing a nuisance after photos of her playing with soap bubbles at her residence were released.
Photo courtesy of Blitzway Entertainment
On the 6th, Son Dam-bi posted on her social media, “I know many of you are worried about the bubble play, but I wiped the floor clean with a towel.”
Previously, Son Dam-bi had shared photos from a family trip to Sokcho, Gangwon Province. Among them was a photo of her playing with bubbles with her daughter at their lodging, and after the photo was posted, netizens criticized her for blowing bubbles indoors.
As the controversy grew, Son Dam-bi stepped forward to clarify the situation.
Son Dam-bi married former national speed skater Lee Kyu-hyuk in 2022 and gave birth to her first daughter in April of last year.

Economy

Corporation

IT·Science

Economy

High Interest Rates and Deteriorating Creditworthiness: A ‘Double Whammy’… Warning Signs as 23 Companies Face Rating Downgrades

As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish busi…
2026-11-20 16:10:05

Corporation

“100 People Line Up Even in Sub-Zero Temperatures”… Olive Young Launches Second ‘K-Color Cosmetics’ Initiative in Hongdae [Report]

On the streets of Hongdae, where morning temperatures had dropped below freezing, one building was bathed entirely in pink. People wearing down jackets with hoods pulled tight lined up along the wall,…
2026-11-20 16:09:57

IT·Science

Aimed Bio Inc.’s ADC Technology Export Shows 60% Response Rate in Phase 1 Clinical Trial… Moving Forward with U.S. Approval Trials

#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…
2026-11-20 13:07:02